Scientific validation of the health claims of matcha is at the core of our mission at OMGTea.  We are working with UK leading medical professionals, conducting scientific and clinical studies which leave no doubt as to the potential health benefits of matcha, for ageing and age related diseases.

Clinical studies in relation to fat oxidation to show how OMGTea enhances healthy weight loss at Chichester University. For the full detail, go to Fat Oxidation Study.

Scientific studies with breast· cancer to highlight· its potential effects on breast cancer stem cells at Salford University· For full details, go to Breast Cancer Study.

All of this research is underpinned by the quality of OMGTea matcha again highlighting how important this is to us.

Our Medical Experts

All of our medical articles are written and or reviewed by a Medical Advisory Board. Our Medical Advisory Board includes doctors, physiotherapists, nutritionists and other healthcare specialists.  

Included on the board is Professor Michael Lisanti who works with OMGTea directly to check and update our articles, and advise us on ways to develop our range of products:


Professor Michael Lisanti

Chair of Translational Medicine at Salford University, Manchester 

Chair of the Healthy Life Foundation Scientific Advisory Board

An active research scientist for more than three decades with a broad background in cell biology and genetics, Professor Lisanti graduated with a degree in Chemistry (Magna Cum Laude) from New York University and obtained his MD-PhD at Cornell University Medical School in Cell Biology and Genetics. From 1992-96, he was a Skeggs Fellow at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT), followed by several distinguished appointments at the Albert Einstein College of Medicine and the Kimmel Cancer Centre. Professor Lisanti joined Manchester University in 2012 as Professor of Cancer Biology. He is currently listed amongst the Top 100 Most-Cited Researchers in Biochemistry and Biology. He has an H-index >120, with over 50,000 citations. Moreover, he has published > 480 papers and is the former Editor-in-Chief of The American Journal of Pathology.